Evidence map›Paper›PMID 41305951›Full record

ArticleChembiochem : a European journal of chemical biology2026

Alteration of CD40 Protein Expression by Tyrosine Phosphorylation of the NF-κB p50 Subunit.

Shengxi Chen, Gal Reddy Potuganti, Xun Ji, Sidney M Hecht

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shengxi ChenBiodesign Center for BioEnergetics, Arizona State University, Tempe, AZ, 85287, USA.ORCID https://orcid.org/0000-0001-7493-6985
Gal Reddy PotugantiBiodesign Center for BioEnergetics, Arizona State University, Tempe, AZ, 85287, USA.
Xun JiBiodesign Center for BioEnergetics, Arizona State University, Tempe, AZ, 85287, USA.
Sidney M HechtBiodesign Center for BioEnergetics, Arizona State University, Tempe, AZ, 85287, USA.ORCID https://orcid.org/0000-0002-5429-2462

Funding

Biological Regulation Studied In Vitro and In Cellulo with Modified ProteinsR35GM140819 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Sidney M. Hecht · 2021 to 2026
$2.9M
National Institute of General Medical Sciences Research R35GM140819NIGMS NIH HHS R35 GM140819NIH HHS
6 · The paper itself

Abstract

Protein phosphorylation is critical to selective gene expression; the proteins that regulate transcription are often phosphorylated at multiple sites. Serine and threonine phosphorylation in transcription factors such as NF-κB has been studied, and specific serines are involved in transcriptional activation. Tyrosine phosphorylation of NF-κB p50 subunit can also facilitate the NF-κB-mediated expression of CD40 protein. This study seeks to determine whether tyrosine phosphorylations at positions not normally phosphorylated in vivo could nonetheless affect protein expression mediated by NF-κB. The alterations studied included p50 analogs having pTyr at positions 59 and 61, which do not contain Tyr naturally, and an analog containing a metabolically stable tyrosine methylene phosphonate at position 60. Additionally, to explore the structural basis for enhanced NF-κB binding to CD40 promoter DNA by tyrosine phosphorylation, an analog of NF-κB p50 containing pTyr at both positions 60 and 82 is prepared. The results reflected changes in the ability of the modified NF-κBs containing an altered p50 subunit to bind to CD40 promoter DNA in vitro, and to direct the synthesis of CD40 in cellulo.

Indexed as

CD40 AntigensNF-kappa B p50 SubunitTyrosineHumansPhosphorylationPromoter Regions, GeneticCD40 AntigensNF-kappa B p50 SubunitTyrosineCD40 regulationin cellulo protein expressionmodified protein synthesisnonsense codon suppressiontyrosine phosphorylation

Identifiers

PMID41305951
PMCPMC12794383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.